Johnson & Johnson (JNJ)
Johnson & Johnson Market Cap: 481.86B for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 168.99B |
| Gilead Sciences, Inc. | 148.08B |
| Eli Lilly & Co. | 878.59B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Protagonist Therapeutics, Inc. | 5.534B |
Market Cap Related Metrics
| PE Ratio | 19.30 |
| PS Ratio | 5.263 |
| PEG Ratio | 0.2708 |
| Price to Book Value | 6.078 |
| Price to Free Cash Flow | 23.70 |
| Price | 200.00 |
| Earnings Yield | 5.18% |
| PEGY Ratio | 0.2615 |
| Operating PE Ratio | 20.41 |
| Normalized PE Ratio | 23.46 |